Company Filing History:
Years Active: 2012
Title: The Innovations of Il-Shin Kim
Introduction
Il-Shin Kim is a notable inventor based in Pohang, South Korea. With a focus on biochemistry and molecular biology, he has made significant contributions to the field, particularly in the area of mammalian target-of-rapamycin (mTOR) regulation. His innovative work has led to two patents that highlight his dedication to improving metabolic health.
Latest Patents
Il-Shin Kim holds two patents related to methods of regulating mTOR activity. The first patent introduces a method of regulating mTOR by interacting with phospholipase D (PLD) and its complex with mTOR. This invention provides a novel approach to screening inhibitors of mTOR and offers therapeutic methods for treating mTOR-related metabolic diseases. The second patent similarly involves regulating mTOR activity but focuses on the interaction between PLD and Ras homolog enriched in brain (Rheb). Both patents emphasize methods and compositions for screening inhibitors and treating metabolic diseases linked to mTOR.
Career Highlights
Currently, Il-Shin Kim is affiliated with the Postech Academy-Industry Foundation, where he leverages his expertise in research and innovation. His work not only contributes to academic knowledge but also bridges the gap between research and practical applications in healthcare.
Collaborations
Throughout his career, Il-Shin Kim has collaborated with esteemed colleagues such as Sung-Ho Ryu and Pann-Ghill Suh. These collaborations enhance the scope of his research and drive forward the potential applications of his inventions in the medical field.
Conclusion
Il-Shin Kim’s contributions through his patents reflect his commitment to advancing scientific knowledge and developing treatments for metabolic diseases. His innovative methods for regulating mTOR activity exemplify the potential of targeted research in improving health outcomes and underscore the importance of collaboration in the innovation process.